Evidence map›Paper›PMID 31182588›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.

Chiara Sorini, Ilaria Cosorich, Marta Lo Conte, Lorena De Giorgi, Federica Facciotti, Roberta Lucianò, Martina Rocchi, Roberto Ferrarese, Francesca Sanvito, Filippo Canducci and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 2 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 2 syntheses or guidelines pooled it, 205 citations in OpenAlex.

  1. Pooled it
  2. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  3. Gut microbes · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Elevated Markers of Intestinal Barrier Dysfunction and TLR2 Ligands in Individuals with Type 1 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Chiara SoriniExperimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Ilaria CosorichExperimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Marta Lo ConteExperimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Lorena De GiorgiExperimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Federica FacciottiDepartment of Experimental Oncology, European Institute of Oncology IRCSS, 20139 Milan, Italy.
Roberta LucianòPathological Anatomy Unit, IRCSS San Raffaele Scientific Institute, 20132 Milan, Italy.
Martina RocchiPathological Anatomy Unit, IRCSS San Raffaele Scientific Institute, 20132 Milan, Italy.
Roberto FerrareseExperimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Francesca SanvitoPathological Anatomy Unit, IRCSS San Raffaele Scientific Institute, 20132 Milan, Italy.
Filippo CanducciDepartment of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
Marika FalconeExperimental Diabetes Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; falcone.marika@hsr.it.
Istituto di Ricovero e Cura a Carattere Scientifico San RaffaeleVita-Salute San Raffaele University · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITEuropean Institute of Oncology · ITKarolinska Institutet · SEUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-grade intestinal inflammation and alterations of gut barrier integrity are found in patients affected by extraintestinal autoimmune diseases such as type 1 diabetes (T1D), but a direct causal link between enteropathy and triggering of autoimmunity is yet to be established. Here, we found that onset of autoimmunity in preclinical models of T1D is associated with alterations of the mucus layer structure and loss of gut barrier integrity. Importantly, we showed that breakage of the gut barrier integrity in

Indexed as

AnimalsBacteriaBlood GlucoseColitisDiabetes Mellitus, Type 1Disease Models, AnimalFemaleGastrointestinal MicrobiomeGene ExpressionHumansIntestinal MucosaIslets of LangerhansMiceMice, Inbred NODMice, TransgenicPermeabilityBlood GlucoseReceptors, Antigen, T-CellSodium Dodecyl Sulfateautoimmune diabetesgut inflammationmicrobiota

Identifiers

PMID31182588
PMCPMC6660755
OpenAlexW2950737242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.